Rasagiline Treatment Report
See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
Rasagiline is a MAO inhibitor which can enhance the activity of dopamine at the synapse. It is sometimes used in early Parkinson's as a monotherapy to enhance naturally existing levels of dopamine, or may be added on as an "adjunct" to other drugs in later stages.
What we've learned
Why Patients Take Rasagiline
| slow my disease's progress | |
|---|---|
| Other | |
| Stiffness/spasticity | |
| Not indicated | |
| Don't know | |
| Fatigue | |
| Disease-related symptoms |
Patient Dosages
| 0.05 mg daily | 0.5 mg daily | 0.75 mg daily | 1.5 mg daily | 1 mg daily | 2 mg daily | 3 mg daily | 5 mg daily | 10 mg daily | 50 mg daily | 100 mg daily | N/A | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2
|
23
|
1
|
2
|
85
|
3
|
1
|
3
|
1
|
1
|
3
|
16
|
||
How Long Current Patients Have Been Taking Rasagiline
Why Patients Stopped Taking Rasagiline (multiple reasons could be selected)
| Doctor's advice | |
|---|---|
| Side effects too severe | |
| Did not seem to work | |
| Expense | |
| Other | |
| Not indicated |
How Long Patients Took Rasagiline Before Stopping
Average:
Rasagiline Ratings
|
|
|
|---|---|
|
|
|
|
|
|
|
|